摘要
多年来,糖皮质激素在风湿病、肾病、血液病及肿瘤等领域的应用越来越广泛,使多种相关疾病的预后得到明显改善,而长期使用糖皮质激素诱导的骨质疏松(GIOP)越来越受到人们的重视。2001年和2010年美国风湿病学会(ACR)总结了有关GIOP的研究进展,先后两次推出了GIOP诊治共识,之后各国纷纷根据国情制定或修订了共识。
出处
《中华风湿病学杂志》
CAS
CSCD
北大核心
2013年第6期361-362,共2页
Chinese Journal of Rheumatology
参考文献13
-
1Mckenzie R, Reynolds JC, CKFallon A, et al. Decreased bonemineral density during low dose glucocorticoid administration in arandomized, placebo controlled trial. J Rheumatol, 2000 , 27:2222-2226. 被引量:1
-
2Recommendations for the prevention and glucocorticoid-inducedosteoporosis: 2001 update. American College of RheumatologyAd Hoc Committee on glucocorticoid-induced osteoporosis.Arthritis Rheum, 2001,44: 1496-1503. 被引量:1
-
3Kaji H, Yamauchi M, Chihara K,et al. The threshold of bonemineral density for vertebral fracture in female patients withglucocorticoid-induced osteoporosis. EndocrJ,2006, 53: 27-34. 被引量:1
-
4Kanis JA, Johansson H, Oden A, et al. A meta-analysis of priorcorticosteroid use and fracture risk. J Bone Miner Res, 2004,19: 893-899. 被引量:1
-
5Kanis JA, Oden A, Johansson H,et al. FRAX and its applica-tions to clinical practice. Bone, 2009, 44: 734-743. 被引量:1
-
6Grossman JM, Gordon R, Ranganath VK, et al. American col-lege of rheumatology 2010 recommendations for the preventionand treatment of glucocorticoid-induced osteoporosis. ArthritisCare Res, 2010,62: 1515-1526. 被引量:1
-
7张学武.2010年美国风湿病学会最新糖皮质激素诱导的骨质疏松共识备受关注[J].中华风湿病学杂志,2011,15(3):145-146. 被引量:21
-
8Bischolf-Ferrari HA, Dawson-Hughes B, Staehelin HB,et al.Fall prevention with supplemental and active forms of vitamin D:a meta analysis of randomised controlled trials. Br Med J, 2009,339: b369. 被引量:1
-
9Black DM,Cummings SR, Karpf D, et al. Randomized trial ofeffect of alendronate on risk of fracture in women with existingvertebral fractures. Lancet, 1996, 348: 1535-1541. 被引量:1
-
10Delmas PD, Recker RR, Chesnut CH IQ , et al. Daily and inter-mittent oral ibandronate normalize bone turnover and providesignificant reduction in vertebralfracture risk: results from theBONE study. Osteoporos Int, 2004,15: 792-798. 被引量:1
二级参考文献10
-
1Mckenzie R, Reynolds JC, O'Fallon A, et al. Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. J Rheumatol, 2000, 27: 2222-2226. 被引量:1
-
2Van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid'induced osteaporosis: a meta-analysis. Osteoporos Int, 2002, 13: 777-787. 被引量:1
-
3Angeli A, Guglielmi G, Dovio A, et al. High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone, 2006, 39: 253-259. 被引量:1
-
4American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum, 2001, 44: 1496-503. 被引量:1
-
5Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior cortieosteroid use and fracture risk. J Bone Miner Res, 2004, 19: 893-899. 被引量:1
-
6Kanish JA Oden A, Johansson H, et al. FRAX and its applications to clinical practice. Bone, 2009, 44: 734-743. 被引量:1
-
7Van Staa TP, Geusens P, Pols HA, et al. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM, 2005, 98: 191-198. 被引量:1
-
8Reid DM, Devogelaer JP, Saag K, et al. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoidinduced osteoporosis (HORIZON): a muhieentre, double-blind, double-dummy, randomised controlled trial. Lancet, 2009, 373: 1253-1263. 被引量:1
-
9Okada Y, Nawata M, Nakayamada S, et al. Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocortieoid therapy. J Rheumatol, 2008, 35: 2249-2254. 被引量:1
-
10Jennifer MG, Rebecca G, Veena KR, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-Induced osteoporosis. Arthritis Care Res, 2010, 62: 1515-1526. 被引量:1
共引文献24
-
1许洁,丁玉.唑来膦酸治疗糖皮质激素所致骨质疏松症的护理[J].江苏医药,2012,38(16):1979-1980. 被引量:2
-
2薛愉,万伟国.糖皮质激素在风湿病治疗中的应用及其并发症的处理[J].上海医药,2012,33(19):25-31. 被引量:8
-
3唐晓颇,姜泉,刘维,王义军,张俊莉,何东仪,钟明,李凤珍,康俊萍,任文肖,黄传兵,朱婉华,李爱民,焦娟,王海隆.清热利湿活血综合疗法治疗活动期类风湿关节炎患者212例疗效分析[J].世界中西医结合杂志,2012,7(11):978-981. 被引量:14
-
4段春霞,任景霞.系统性红斑狼疮患者的护理体会[J].基层医学论坛,2012,16(33):4397-4398. 被引量:2
-
5瞿霞.老年骨质疏松症的中医食疗[J].内蒙古中医药,2013,32(1):140-141. 被引量:5
-
6章振林.原发性骨质疏松症治疗药物及疗效随访原则[J].上海医药,2013,34(9):1-5. 被引量:7
-
7刘湘源,张学武.糖皮质激素诱导的骨质疏松诊治的专家共识[J].中华风湿病学杂志,2013,17(6):363-368. 被引量:66
-
8乐曦,蒋辉,李纯芬.唑来膦酸钠治疗老年骨质疏松症不良反应的观察及护理对策[J].检验医学与临床,2013,10(17):2324-2325. 被引量:4
-
9温振团.长期吸入糖皮质激素对佛山区域中老年人群骨代谢影响的调查[J].中国当代医药,2013,20(30):49-50.
-
10林炎水,林杨景,肖建平,刘金望,贺军,向登.打压植骨联合骨小梁金属髋臼杯在骨质疏松患者全髋关节置换术中的应用[J].成都医学院学报,2013,8(5):599-601. 被引量:1
同被引文献108
-
1李姝玉,胡大伟.系统性红斑狼疮患者骨质疏松的相关因素[J].中国骨质疏松杂志,2007,13(6):447-450. 被引量:5
-
2杨瑞红,何权瀛,栗占国.风湿病相关性间质性肺病临床特点及治疗分析[J].中华风湿病学杂志,2007,11(12):736-738. 被引量:9
-
3Buttgereit FR, Iipworth BJ. Optimised glucocorticoid therapy:the sharpe- ning of an old spear[ J~. Lancet,2005,365 (9461) :801-803. 被引量:1
-
4Den Uyl DE, Lems WF. Advances in glucocorticoid-induced osteoporosis[J]. Curr Rheumatol Rep ,2011,13 (3) :233-240. 被引量:1
-
5Stewart PM, Krozowski ZS. 11 beta-hydroxysteroid dehydrogenase [ J 1. Vitam Horm, 1999, 57:249-324. 被引量:1
-
6Mckay LI, Cidlowski JA.Cross-talk between nuclear factor-kappa B and the steroid hormone receptors : mechanisms of mutual antagonism [ J ]. Mol Endocrinol, 1998,12 ( 1 ) :45-56. 被引量:1
-
7Vayssiere BM, Dupont S, Choquart A, et al. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiin- flammatory activity in vivo[ J ]. Mol Endocrinol, 1997, 11 (9) :1245- 1255. 被引量:1
-
8Buttgereit F, Straub RH, Wehling M, et al. Glucocorticoids in the treat- ment of rheumatic diseases: an update on the mechanisms of action [ J ]. Arthritis Rheum ,2004,50 ( 11 ) :3408-3417. 被引量:1
-
9Aulakh R, Singh S. Strategies for minimizing corticosteroid toxicity: a review [ J 1. Indian J Pediatr,2008,75 (10) : 1067-1073. 被引量:1
-
10Curtis JR,Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucoeorticoid use [ J ]. Arthritis Rheum ,2006,55 ( 3 ) :420-426. 被引量:1
引证文献6
-
1周晓,孙伟,隋晓杰,王向波.糖皮质激素引发骨质疏松或骨坏死等不良反应研究进展[J].疑难病杂志,2015,14(5):534-540. 被引量:25
-
2林岩.慢性肾脏病患者糖皮质激素性骨质疏松的诊治进展[J].吉林医药学院学报,2015,36(3):209-212. 被引量:1
-
3王晓非,徐京京.系统性红斑狼疮相关骨质疏松[J].中国实用内科杂志,2015,35(10):810-813. 被引量:7
-
4石亚妹,武丽君.糖皮质激素诱导的骨质疏松症的认识及防治进展[J].新疆医学,2017,47(12):1343-1345. 被引量:1
-
5何权瀛.不识庐山真面目,只因不在此山中:有关风湿病的几点刍议[J].中华风湿病学杂志,2019,23(7):433-435.
-
6万琦.糖皮质激素在风湿免疫病治疗中的使用观察[J].中国妇幼健康研究,2017,28(S2):325-326. 被引量:1
二级引证文献35
-
1刘润荣,刘亚婧,管春晓.绝经前系统性红斑狼疮患者骨密度及骨转换标志物测定的临床意义[J].潍坊医学院学报,2023,45(3):221-223.
-
2付雪梅,王亮,马远征,李州利,张妍,苏天娇,陈立英,徐小文,马伟凤,谢媛媛,杨帆,马彦巧,陈琼,王天天,孙杨.移植肾受者的骨质疏松研究进展[J].中国骨质疏松杂志,2015,21(12):1508-1511. 被引量:1
-
3高雅,王晓非.胸腺基质淋巴细胞生成素在类风湿关节炎和有关节症状的系统性红斑狼疮患者外周血中的表达及其意义[J].吉林大学学报(医学版),2016,42(3):556-560. 被引量:4
-
4庞琳烜,郑朝晖,杨西超,谢荣华,吴振彪.类风湿关节炎发生骨质疏松骨折影响因素分析[J].解放军医药杂志,2016,28(6):69-72. 被引量:9
-
5郭嘉俊,张小灵,张慧迪,时军.芎柰抗骨关节炎有效部位研究[J].广东药学院学报,2016,32(4):470-474. 被引量:2
-
6卢烁,郝斌.系统性红斑狼疮股骨头坏死发病机制研究进展[J].解放军医药杂志,2016,28(10):112-116. 被引量:6
-
7周友龙,郭光昕,宁文华,李继萍,朱紫燕,李俊飞,郭明菲,党琦.医用臭氧水治疗腰椎间盘突出症神经根炎80例[J].中医临床研究,2016,8(29):46-47. 被引量:5
-
8许诚.不同剂量糖皮质激素治疗系统性红斑狼疮的临床疗效及对骨骼的影响[J].医学综述,2017,23(6):1238-1241. 被引量:16
-
9严正杰,戴有金,侯道荣.白介素-10对去卵巢小鼠骨质疏松的作用[J].中国医药导报,2017,14(10):39-42. 被引量:13
-
10刘娜,侯继秋.临床药师对支气管哮喘合并肺栓塞、肺部感染患者的药学监护[J].中国医院用药评价与分析,2017,17(4):560-562. 被引量:5
-
1许洁,丁玉.唑来膦酸治疗糖皮质激素所致骨质疏松症的护理[J].江苏医药,2012,38(16):1979-1980. 被引量:2
-
2蒋颖,张奉春,唐福林.糖皮质激素诱导的骨质疏松的防治策略[J].中华老年医学杂志,2008,27(7):559-560. 被引量:1
-
3蒋颖,张奉春.糖皮质激素诱导的骨质疏松[J].中华老年医学杂志,2008,27(1):76-78.
-
4吴琨,王国春,周惠琼.糖皮质激素诱导骨质疏松的诊治进展[J].中日友好医院学报,2010,24(5):307-310. 被引量:7
-
5邢小平.糖皮质激素诱导的骨质疏松[J].中国医刊,2006,41(10):8-10. 被引量:2
-
6连莉,徐建华.糖皮质激素性骨质疏松防治进展[J].临床内科杂志,2011,28(10):653-655. 被引量:2
-
7马洪福,张睢扬,王英,王东霞.糖皮质激素诱导的高血糖和糖尿病在呼吸系统疾病的诊治现状[J].国际呼吸杂志,2014,34(11):870-873. 被引量:3
-
8Luigi,Gennari,John,P,Bilezikian,邓斌(译).糖皮质激素诱导的骨质疏松症:寄希望于HORIZON[J].世界临床医学,2009(12):999-1000.
-
9张学武.风湿病患者中糖皮质激素性骨质疏松的诊治值得关注[J].中华风湿病学杂志,2008,12(10):657-659. 被引量:2
-
10邓斌(译).唑来膦酸与利塞膦酸钠预防和治疗糖皮质激素诱导的骨质疏松症(HORIZON):一项多中心、双盲、双模拟随机对照试验[J].世界临床医学,2009(12):1067-1067. 被引量:3